Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chu

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Cancer Research|November 1, 2008
A history of cancer chemotherapyVincent T DeVita, Edward Chu
Clinical Colorectal Cancer|August 20, 2020
The UPMC Hillman Cancer Center Approach to the Management of Colorectal Cancer During the COVID-19 Pandemic EraJames J Lee, Edward Chu
British Journal of Anaesthesia|December 7, 2021
Improving mass casualty planning in low resource settings: Médecins Sans Frontières and International Committee of the Red Cross perspectiveEdward Chu, Nurhayati Lubis, Roger Alcock
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted ApproachesChloe E Atreya, Rona Yaeger, Edward Chu
The Journal of Supportive Oncology|May 27, 2006
Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapyEdward Chu, Lawrence H Einhorn, Patrick Lefebvre
Clinical Advances in Hematology & Oncology : H&O|April 21, 2009
KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitorsHeinz-Josef Lenz, Edward Chu, Axel Grothey
Clinical Colorectal Cancer|June 11, 2021
Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine-Based Chemotherapy in Patients With Early-Stage Colon CancerXue Wang, Maxfield M Frohlich, Edward Chu
Clinical Colorectal Cancer|July 25, 2008
Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008Tara Beers Gibson, Erin Grothey, Edward Chu
JAMA Oncology|October 20, 2022
All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow LaneJan H Beumer, Edward Chu, Salvatore J Salamone
Nucleic Acids Research|August 9, 2003
Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthaseXiukun Lin, Jun Liu, Frank Maley, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Cancer Research|November 1, 2008
A history of cancer chemotherapyVincent T DeVita, Edward Chu
Clinical Colorectal Cancer|August 20, 2020
The UPMC Hillman Cancer Center Approach to the Management of Colorectal Cancer During the COVID-19 Pandemic EraJames J Lee, Edward Chu
British Journal of Anaesthesia|December 7, 2021
Improving mass casualty planning in low resource settings: Médecins Sans Frontières and International Committee of the Red Cross perspectiveEdward Chu, Nurhayati Lubis, Roger Alcock
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted ApproachesChloe E Atreya, Rona Yaeger, Edward Chu
The Journal of Supportive Oncology|May 27, 2006
Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapyEdward Chu, Lawrence H Einhorn, Patrick Lefebvre
Clinical Advances in Hematology & Oncology : H&O|April 21, 2009
KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitorsHeinz-Josef Lenz, Edward Chu, Axel Grothey
Clinical Colorectal Cancer|June 11, 2021
Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine-Based Chemotherapy in Patients With Early-Stage Colon CancerXue Wang, Maxfield M Frohlich, Edward Chu
Clinical Colorectal Cancer|July 25, 2008
Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008Tara Beers Gibson, Erin Grothey, Edward Chu
JAMA Oncology|October 20, 2022
All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow LaneJan H Beumer, Edward Chu, Salvatore J Salamone
Nucleic Acids Research|August 9, 2003
Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthaseXiukun Lin, Jun Liu, Frank Maley, et al.
Pageof 22